Frontlight ResearchEarly access
Trial site
Medical University of South Carolina- University Hospital
- 8running trials
- 1closed trial
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Stroke8 trials
- Acute myeloid leukaemia1 trial
- Atrial fibrillation1 trial
- Coronary artery disease1 trial
- Myelodysplastic syndromes1 trial
- Phase
- Phase 35 trials
- Phase 22 trials
- Phase 11 trial
- Status
- Recruiting5 trials
- Active, not recruiting3 trials
- Completed1 trial
- Lead sponsor
- Joseph Broderick, MD2 trials
- Duke University1 trial
- Medical University of South Carolina1 trial
- Seagen, a wholly owned subsidiary of Pfizer1 trial
- Stanford University1 trial
- and 3 more
Running trials
Recruiting
Recruiting
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Recruiting
Recruiting
Active, not recruiting
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis
Active, not recruiting
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial
Active, not recruiting
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Stroke5 recruiting
- Atrial fibrillation1 recruiting
- Coronary artery disease1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 19 Nov 2026